跳至主要内容
临床试验/NCT02255539
NCT02255539已完成不适用

Bioburden and Usability Study of the Geelong Mask System

ResMed1 个研究点 分布在 1 个国家目标入组 42 人开始时间: 2015年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
42
试验地点
1
主要终点
Changes from baseline in Bioburden and Impedance of the prototype mask components at 6 weeks

研究概览

简要总结

AIM AND HYPOTHESIS: The purpose of this study is to monitor the bioburden and impedance characteristics of a prototype mask system and to evaluate the usability of the mask system. The mask system will be assessed according to objective data recordings and user questionnaires. It is hypothesised that the prototype mask components will not pose a health risk (with regards to bioburden and impedance) and that the mask system will pass usability objectives to adequately deliver CPAP treatment.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Participants willing to give written informed consent
  • •Participants who can read and comprehend written and spoken English
  • •Participants who are over 18 years of age
  • •Participants who have been diagnosed with OSA
  • •Participants who have been established on CPAP for ≥ 6 months
  • •Participants currently using a ResMed nasal pillows mask

排除标准

  • •Participants who are not able to provide written informed consent
  • •Participants who are unable to comprehend written and spoken English
  • •Participants who are pregnant
  • •Participants who are unsuitable to participate in the study in the opinion of the researcher
  • •Participants with a pre-existing lung disease or a condition that would predispose them to pneumothorax (e.g. COPD, lung cancer; fibrosis of the lungs; recent (< 2years) case of pneumonia or lung infection, lung injury)
  • •Participants who cannot participate for the duration of the trial
  • •Participants who are established on bi-level support therapy
  • •Participants who are not established on a ResMed nasal pillows mask

研究组 & 干预措施

CPAP Nasal Mask

Experimental

Geelong Prototype Mask

干预措施: Geelong Prototype Mask (Device)

结局指标

主要结局

Changes from baseline in Bioburden and Impedance of the prototype mask components at 6 weeks

时间窗: 6 weeks

The population of microorganisms on mask components will be measured after 6 weeks of continuous use by a participant on their PAP therapy device to assess the safe replacement interval of the component. The impedance of the mask will also be measured to assess whether the build up of microorganisms on the mask component will affect the usability and effectiveness of the mask. Bioburden and impedance testing will be conducted in a lab environment on return of the prototype mask and components.

次要结局

  • Usability ratings of the prototype mask using a visual analog scale, compared to a reference level and the participant's current mask(6 weeks)

研究者

发起方
ResMed
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验